ERNA · Ernexa Therapeutics Inc.
AI read · Neutral
The AI's read
This adds a recurring cash cost, but the filing does not say it changes the consultant's duties or the rest of the agreement. It reports no new business results, so the stated facts do not point to a wider change in Ernexa's outlook.